Feed Lot

MAR 2018

Feedlots and cow/calf operations in the beef industry who feed 500 or more has annually on grains and concentrates; maintain 500 or more beef cows; backgrounder, stocker/grower, preconditioner; veterinarian, nutritionist, consultant

Issue link: https://feedlotmagazine.epubxp.com/i/948915

Contents of this Issue


Page 11 of 31

12 FEED•LOT  March 2018 FEEDLOT FOCUS Thanks to educational programs and information, as well as an in- dustry-wide push for beef quality assurance, the eating experience for consumers has increased in both quality and consistency. Injec- tion site education, following with- drawal times, pharmaceutical mode of application options, cattle handling and other improvements have helped the industry signifi- cantly since the early 1990s. According to BQA educator Dr. Ron Gill, following beef quality as- surance guidelines are not only good for the industry, but also for the cattle owner. Following label directions for route of administra- tion ensures pharmaceutical prod- ucts work like they are designed to and minimize tissue damage. "If you're going to take the effort and expense to give a product, ad- ministering it according to label di- rections will help ensure it's going to work as intended. If you don't de- liver it correctly, you might not get the results you expect," Gill said. Once you go off label, you don't know the absorption rate, with- drawal time and efficacy of the product, he said. A similar issue occurs when too much of a product is injected in one place. Most products recom- mend no more than 10cc at a single injection site location. More than 10cc can lead to the product not being absorbed appropriately. Improper injection techniques can also increase tissue damage resulting in more trim on the car- cass and will affect the tenderness of meat in the area of an intra-mus- cular injection. "That's why all IM injections should go in the neck," Gill states. A new product released in Feb- ruary hopes to make it easier for cattlemen to use and follow label directions, insuring an accurate withdrawal time and efficacy when administered correctly. Banamine Transdermal (flunixin transdermal solution) from Merck Animal Health offers a new pour-on route of ad- ministration, compared to tradi- tional injectable flunixin meglumin. Banamine Transdermal is the first and only non-steroidal, anti- inflammatory (NSAID) cattle prod- uct available as a pour-on, and the first product ever to be licensed with a pain indication for food animals Flunixin meglumin injectable products are labeled for intra- venous (IV) use in cattle, and have a four-day withdrawal. Because IV administration can be difficult, the injectable product has often been administered either IM or SQ, which can change the withdrawal to as much as 60 days, according to Scott Nordstrom, DVM, Assistant Director of New Product Discov- ery and Development for Merck Animal Health According to the FDA, extra-la- bel use of drugs without written di- rection by a veterinarian in food- producing animals is a significant public health concern and a con- tributing factor in illegal residues in edible animal tissue. Such use of drugs is illegal under the Federal Food, Drug, and Cosmetic Act. Flunixin meglumine has been one of the common causes of meat residue violations in cattle. Accord- ing to Nordstrom, "Merck Animal Health understands the impor- tance of flunixin meglumine's use in treating cattle and worked to find an easier way to administer it. The pour-on application eliminates injection-site lesions within the car- cass at marketing and reduces risk of residues, resulting in a signifi- cant improvement in food safety." Good record keeping is key to protecting yourself in the event of a residue violation, Gill said. "If it's your first violation, they will often see what your records are, and if you're trying to follow guidelines. Repeat offenders can be fined and habitual violators can ultimately be banned from owning livestock," he said. "Even if you are administering a product to stocker cattle that you think wouldn't enter the food chain for several months, withdrawal times are important," said Gill. "If you're giving something off label, you can have a withdrawal issue. If one of those stocker claves had to be harvested early, then a residue could be in the meat. You can't assume that calf would go to another rancher or stocker opera- tor. Once they leave your property, you have no control whether they enter the food chain or not." FL Use Caution with Extra-Label Use Administering products off-label can result in decreased efficacy and withdrawal concerns By JILL J. DUNKEL New Product, New Application Merck Animal Health's introduction of Banamine Transdermal brings to the market the only FDA approved product for pain control in a food producing animal. It is approved for the control of pain associated with foot rot and fever associated with bovine respiratory disease. "Banamine Transdermal aligns with industry initiatives to continuously improve animal care and mitigate pain" said Nordstrom. "There's a lot of quality research behind this new product. Topical administration gets past any obstacles we have had in the past with the level of training and skill required to give flunixin on label. We now have the technologies to make this work for cattle, in an easy to administer product without any negative side effects." Banamine Transdermal is also the first non-parasiticide product for cattle that is administered as a pour-on.

Articles in this issue

Archives of this issue

view archives of Feed Lot - MAR 2018